Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The putative distinct diagnostic and pathogenic potential of aDNA-Ab subtypes, differing in their affinity or epitope specificity, was subject of several studies with controversial results. Comparing five assays, characterized by different reaction conditions and nature/source of dsDNA, we investigated the abovementioned problem in a retrospective study on 100 systemic lupus erythematosus (SLE) patients and 100 controls (other CTD, autoimmune hepatopathies). As demonstrated, only assay 3 (Farrzyme, TBS, UK) and 5 (Farr-RIA, Trinity Biotech, Ireland) are really suitable to detect primarily high avidity aDNA-Ab. Both were significantly linked to lupus nephritis (specificity 84%) and highly specific for SLE (95 and 96%). Thereby, assay 3 was found to be the first solid phase ELISA probably suitable to replace the Farr-RIA. Classical ELISAs (assay 1, Orgentec, Germany, and 2, Bindazyme, TBS, UK), detecting aDNA-Ab more or less independent from their avidity, or tests with only intermediate specificity for high avidity Ab (assay 4, ELIAdn, Sweden Diagnostics, Germany), were less specific for SLE (83, 79, 91%, respectively) and not associated with renal involvement (specificity 54-57%). At least in the patients studied here, obvious antigen-related differences could not be observed. With slight differences, all assays were suitable to monitor disease activity and therapy in SLE, agreeing with the ECLAM score in about 70-80% of cases. For lupus nephritis, aC1q-Ab are as specific as high avidity aDNA-Ab and capable to close a diagnostic gap in some cases. Thus, to enhance the specificity (up to 98%) and to consider the distinct diagnostic/pathogenic potential of aDNA-Ab subtypes in SLE, under routine clinical laboratory conditions it should be recommended to combine a sensitive screening test with a more specific second assay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some studies/assays showed no correlation between SLEDAI and antibody level by ELISA [50], whereas others did [43], [45], [48], [58], [64], [66].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [45]
In the citing paper
“Mainly assays that detect high avidity antibodies showed a correlation with disease activity or lupus nephritis [45], [58], [64].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [45]
In the citing paper
“| ELISA The Binding Site (Farrzyme) | 95.0 [90.2-96.0] | 52.0 [36.0-60.6] | 43, 45, 58 | |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [45]
In the citing paper
“| Orgentec | 83.0 [78.4-96.5] | 82.6 [63.0-82.7] | 39, 45, 58 | |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [45]
In the citing paper
“| ELISA The Binding Site (Farrzyme) | 95.0 [90.2-96.0] | 52.0 [36.0-60.6] | 43, 45, 58 | |”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [45]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J. A., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Vitali, C., Bencivelli, W., Isenberg, D. A., Smolen, J. S., Snaith, M. L., Sciuto, M. E., Neri, R., & Bombardieri, S. (1992) · PubMed · Cited by 317
Riemekasten, G., Marell, J., Trebeljahr, G., Klein, R., Hausdorf, G., Häupl, T., Schneider-Mergener, J., Burmester, G. R., & Hiepe, F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2749 · Cited by 286
The cutaneous pathology of lupus erythematosus: a review
Crowson, A. N., & Magro, C. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.280101.x · Cited by 264
Okamura, M., Kanayama, Y., Amastu, K., Negoro, N., Kohda, S., Takeda, T., & Inoue, T. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.1.14 · Cited by 158
Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients
Nossent, J. C., Henzen-Logmans, S. C., Feltkamp‐Vroom, T. M., Berden, J. H. M., & Swaak, T. J. G. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330708 · Cited by 154
Förger, F., Matthias, T., Oppermann, M., Becker, H., & Helmke, K. (2004) · Lupus · doi:10.1191/0961203304lu485oa · Cited by 139
Cross‐reactivity of human lupus anti‐DNA antibodies with α‐actinin and nephritogenic potential
Zhao, Z., Weinstein, E., Tuzova, M., Davidson, A., Mundel, P., Marambio, P., & Putterman, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20862 · Cited by 116
Uwatoko, S., & Mannik, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113684 · Cited by 115
Research works printed but not linked: 5
- Tan EM, 1982, Arthritis Rheum, 25, 271
- Vitali C, 1992, Clin Exp Rheumatol, 10, 541
- Linnemann M, 2002, Clin Lab, 48, 45
- Budd R, 2005, Clin Chem, 51, pA75
- Miehle N, 2004, From animal models to human genetics: Research on the induction and pathogenicity of autoantibodies, 350
Cited by
Bertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007
Mechanisms of killing by anti-CD20 monoclonal antibodies
Glennie, M. J., French, R. R., Cragg, M. S., & Taylor, R. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.151 · Cited by 515
Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117200 · Cited by 377
Gordon, C., Amissah-Arthur, M.-B., Gayed, M., Brown, S., Bruce, I. N., D’Cruz, D., Empson, B., Griffiths, B., Jayne, D., Khamashta, M., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/kex286 · Cited by 365
The Diagnosis and Treatment of Systemic Lupus Erythematosus
Kuhn, A., Bonsmann, G., Anders, H.-J., Herzer, P., Tenbrock, K., & Schneider, M. (2015) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2015.0423 · Cited by 230
Metadata
- Authors
- Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E.
- Affiliations
- Dietrich Bonhoeffer Klinikum (DE)
- Clinic of Internal Medicine, Dept of Rheumatology, Hospital Demmin, Germany
- Corresponding author
- Jaekel, H-P
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2006-06
- Volume
- 15
- Issue
- 6
- Pages
- 335-345
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2119504302
- Semantic Scholar
- 8c5cfada6c197f7fa8d76c6ad6a7b0a0b711b09d
- Cited by
- 43
- References
- 35
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 8
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universität Heidelberg
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- anti-dsDNA antibodies, anti-C1q antibodies, systemic lupus erythematosus, lupus nephritis, antibody avidity, ELISA comparison, disease activity monitoring, diagnostic specificity
- MeSH terms
- Adult, Antibody Affinity, Antibody Specificity, Epitopes, Antibodies, Antinuclear, Autoantigens, Connective Tissue Diseases, DNA, Enzyme-Linked Immunosorbent Assay, Female, Humans, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Predictive Value of Tests, Retrospective Studies, ROC Curve, Sensitivity and Specificity, Severity of Illness Index, Complement C1q
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. https://app.cochat.ai/papers/10.1191/0961203306lu2308oa
- The paper
- Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E. (2006). Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus. https://doi.org/10.1191/0961203306lu2308oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.